投稿信息
投稿信息
审稿速度
平均1.86月
（网友贡献，非官方数据）
投稿命中率
40.48%
（网友贡献，非官方数据）
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2019年中国人文章占该期刊总数量17.58% (2018年为4.32%)
自引率
2.6 %
年文章数
91
NCBI查询
偏重的研究方向
期刊简介
稿件收录要求
稿件收录要求
Published by Springer.
ISSN: 1357-0560.
Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly with experimental therapeutics with the field of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies in oncology and hematology. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.
ISSN: 1357-0560.
Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly with experimental therapeutics with the field of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies in oncology and hematology. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.
- Covers clinical and experimental research in oncology and hematology
- Focuses on experimental therapeutics in the field of immunotherapy and chemotherapy
- Coverage includes immunobiology, pathogenesis, and treatment of malignant tumors